New Therapies for Kidney Disease with XORTX Therapeutics CEO, Allen Davidoff, PhD

from Rx for Biotech · host Podcast Host Chris Leidli

Allen Davidoff, PhD is the Founder and CEO of XORTX Therapeutics, Inc., a drug based biotechnology company primarily focused on orphan disease indications which have aberrant purine metabolism and frequently high serum uric acid imbalance. This podcast episodes looks at novel therapies in development that may extend kidney health.

Episode metadata supplied by the publisher feed · Published Mar 29, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

New Therapies for Kidney Disease with XORTX Therapeutics CEO, Allen Davidoff, PhD

0:00 29:12

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 29 minutes long.

When was this Rx for Biotech episode published?

This episode was published on March 29, 2023.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!